Longeveron Inc. (LGVN)
NCM – Real vaqt narxi. Valyuta: USD
0.75
-0.09 (-10.48%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.77
+0.02 (2.55%)
Bozordan keyin: May 12, 2026, 7:44 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.75
-0.09 (-10.48%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.77
+0.02 (2.55%)
Bozordan keyin: May 12, 2026, 7:44 PM EDT
Longeveron Inc. klinik bosqichdagi biotexnologiya kompaniyasi bo'lib, Qo'shma Shtatlarda qarish bilan bog'liq va hayot uchun xavfli kasalliklar uchun hujayrali terapiyalarni ishlab chiqadi. Uning etakchi tadqiqot mahsuloti LOMECEL-B, yosh va sog'lom kattalar donorlarining suyak iligidan olingan allogenik mezenximal stam hujayra formulasi bo'lib, gipoplastik chap yurak sindromini davolash uchun 3-faza klinik sinovidan o'tmoqda; Altsgeymer kasalligini davolash uchun 2a fazali klinik sinovni yakunladi, shuningdek, qarish zaifligini davolash uchun 2b fazali klinik sinovdan o'tmoqda. Kompaniya 2014-yilda tashkil etilgan va Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joshua Michael Hare FACC, M.D. | Co-Founder, Chief Science Officer & Executive Chairman |
| Dr. Nataliya Agafonova M.D. | Chief Medical Officer |
| Mr. Brian G Rash Ph.D. | Vice President of Research & Discovery |
| Mr. Devin Blass | CTO and Senior VP of Chemistry, Manufacturing & Controls |
| Mr. Paul T. Lehr J.D. | General Counsel & Secretary |
| Mr. Stephen H. Willard Esq. | Chief Executive Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 8-K | ea0289853-8k_longeveron.htm |
| 2026-05-05 | PRE 14A | ea0289252-01.htm |
| 2026-04-10 | S-1 | ea0285827-s1_longeveron.htm |
| 2026-04-10 | 8-K | ea0285933-8k_longeveron.htm |
| 2026-03-25 | D | |
| 2026-03-24 | 8-K | ea0283108-8k_longeveron.htm |
| 2026-03-17 | 10-K | lgvn-20251231.htm |
| 2026-03-12 | 8-K | ea0281100-8k_longeveron.htm |
| 2026-03-09 | 8-K | ea0280382-8k_longeveron.htm |
| 2026-03-03 | PRE 14A | ea0279469-01.htm |
| Ms. Lisa McClain-Moss | Vice President of Manufacturing |
| Ms. Lisa A. Locklear M.B.A. | CFO, Executive VP & Treasurer |